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ENGLISH SUMMARY 
In Denmark, approximately 12,000 people each year suffer from the occlusion of 
one or several blood vessels within the brain, and approximately 30,000 - 40,000 
people are currently living with impacts related to stroke incidents. The pathophys-
iological processes that occur after an ischemic stroke evolve over time and space 
and are dependent on the severity and location of the ischemia. As a consequence, it 
is difficult to monitor and predict how ischemia will develop, and it is highly com-
plicated to design effective neuroprotection and rehabilitation interventions. As 
such, there is a need for alternative and innovative techniques that can monitor is-
chemic stroke and that can assess the potential benefits of novel approaches for 
neuroprotection and rehabilitation interventions.  
This thesis hypothesizes that utilizing microelectrode arrays to monitor intracortical 
electrophysiological signals will provide novel insight into ischemic stroke and can 
be a useful tool when testing novel approaches for neuroprotection and rehabilitation 
interventions. 
To address this hypothesis, four studies were designed based on an ischemic stroke 
model in rats. The objective in Study I was to develop and test a novel microelec-
trode array and data analysis techniques for use in the ischemic stroke model. The 
results showed that the techniques allowed for a detailed spatial and temporal char-
acterization of the acute electrophysiological changes. Studies II & III investigated 
the neuroprotective effect of low-frequency electrical stimulation (lf-ES) applied to 
the ischemic brain in the acute phase following ischemic stroke. Study II demon-
strated that ischemic stroke resulted in acute hyperexcitability of the neural tissue 
located within the penumbra and/or lesser ischemia-affected regions. Lf-ES applied 
to the ischemic brain reduced the overall amount of hyperexcitability, which sug-
gests that the ongoing expansion of the ischemic core can possibly be delayed and 
reduced in volume. Study III showed how hyperexcitability spread along a complex 
path influenced by time, space and neural connectivity and that the application of lf-
ES minimized this spatial and temporal spreading within the affected tissue. Study 
IV explored how the timing of the rehabilitation onset affects the recovery within 
the subacute and chronic phases of ischemic stroke. The study indicated that rehabil-
itation initiated at seven days post ischemic stroke resulted in improved motor func-
tion and neural activity patterns that were more similar to those of the healthy state 
compared to initiating the physical training on day one post ischemic stroke. The 
results support the existence of a critical period where rehabilitation may be more 
efficient in promoting recovery and indicate that initiating rehabilitation prior to this 
period may exacerbate the ischemic injury.  
The thesis showed that intracortical electrophysiological recordings are a useful tool 
to provide new insights into ischemic stroke and demonstrated the beneficial effects 
of novel approaches for neuroprotection and rehabilitation interventions. This work 
may be a basis for further studies on ischemic stroke and may assist in the design of 
more effective interventions for stroke patients in the future. 
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DANISH SUMMARY 
I Danmark rammes ca. 12.000 mennesker årligt af en blodprop (dvs. okklusion af én 
eller  flere blodårer) i hjernen og omkring 30.000 - 40.000 mennesker lever aktuelt 
med følgervirkninger heraf. De patofysiologiske processer, som forekommer efter 
en blodprop, udvikler sig over tid og sted, og afhænger af okklusionens omfang og 
placering i hjernen. Således kan det være svært at forudsige, hvordan iskæmien 
udvikler sig og dermed yderst kompliceret at designe effektive vævsbevarings- og 
rehabiliteringsinterventioner. Af denne grund er der brug for nye metoder til at 
monitorere iskæmisk apopleksi samt undersøge effekten af innovative 
vævsbevarings- og rehabiliteringsinterventioner. 
Hypotesen i denne afhandling er, at brugen af mikroelektrode arrays til at 
monitorere hjernens intrakortikale elektrofysiologiske kommunikation kan give ny 
viden om iskæmisk apopleksi samt være et nyttigt redskab ved test af innovative 
vævsbevarings- og rehabiliteringsinterventioner. 
Fire studier  blev opstillet for at undersøge hypotesen. Alle studierne gjorde brug af 
en rottemodel af iskæmisk apopleksi. Målet med Studie I var at udvikle og teste en 
ny mikroelektrode array og nye metoder til dataanalyse. Resultaterne viste, at de nye 
tiltag gjorde det muligt at karakterisere de akutte ændringer i hjernens 
kommunikation med en høj temporal og spatial nøjagtighed. Studie II & III 
undersøgte den vævsbevarende effekt af lavfrekvent elektrisk stimulation (lf-ES), 
udført direkte på den påvirkede del af hjernen, under den akutte fase efter en 
blodprop. Studie II viste, at der opstod akut hyperexcitabilitet indenfor de lettere 
påvirkede områder af hjernen. Lf-ES reducerede den totale mængde af 
hyperexcitabilitet, hvilket potentielt kan indikere, at interventionen kunne forsinke 
og reducere vævsskade. Studie III viste, at hyperexcitabilitet spredtes over tid og 
sted igennem de neurale forbindelser i hjernen. En spredning som lf-ES viste sig at 
være i stand til at reducere. Studie IV udforskede, om tidspunktet for opstart på 
rehabilitering påvirker, hvor meget hjernen kommer sig efter en blodprop. Studiet 
indikerede, at rehabilitering, som blev opstartet syv dage efter blodproppen, 
resulterede i forbedret motorisk funktion samt hjerneaktivitetsmønstre, som var mere 
ens med raske væv. Opstart på rehabilitation en dag efter blodproppen resulterede 
derimod i dårligere motorisk funktion samt mere forskellige hjerneaktivitetsmønstre. 
Samlet set underbygger resultaterne eksistensen af en kritisk periode efter 
blodpropper, hvor opstart på rehabilitering er mere givtig og indikerer samtidig, at 
opstart på rehabilitering tidligere end den kritiske periode potentielt kan forværre 
skaden. 
Overordnet demonsterer afhandlingen, at intrakortikale elektrofysiologiske målinger 
kan være et nyttigt redskab til at opnå ny viden om iskæmisk apopleksi og 
dokumenterede positive effekter af innovative vævsbevarings- og 
rehabiliteringsinterventioner. På denne måde kan afhandlingens resultater være basis 
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for fremtidige studier indenfor iskæmisk apopleksi og være brugbare i forbindelse 
med udvikling af mere effektive interventioner til behandling i fremtiden. 
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CHAPTER 1. INTRODUCTION 
Ischemic stroke is a consequence of a permanent or transient decrease in blood flow 
within the region of the brain supplied by the affected vessel(s). The typical causes 
of ischemic stroke are embolic or thrombotic events causing the occlusion of the 
affected blood vessel(s) and resulting in dysfunction and death of neurons within the 
brain (Kunz, Dirnagl, & Mergenthaler, 2010). In Denmark, approximately 12,000 
people each year suffer from the occlusion of one or several blood vessels within the 
brain, and 30,000 - 40,000 people are currently suffering from impacts related to 
ischemic stroke (Rostrup Kruuse, 2014). 
The acute pathophysiological processes that occur following the ischemic insult 
evolve over time and space and are dependent on the severity and location of the 
ischemia. To further increase the complexity, several of the processes have a 'Janus-
faced' nature, with both beneficial and damaging effects (Endres et al., 2008; 
Wieloch & Nikolich, 2006). The direct consequence of the ischemic insult (i.e., cell 
death and injury) is observed within the most severely affected ischemic territory, 
whereas changes in non-injured neural tissue may occur as the connections between 
neural networks are destabilized (Carrera & Tononi, 2014). Thus, the behavioral 
deficits observed within the acute phase are reflected not only in the amount of dead 
or injured tissue but also in the degree of malfunction in non-injured neural net-
works (Witte, Bidmon, Schiene, Redecker, & Hagemann, 2000). Following the 
acute phase, recovery may occur via repair of the injured neural networks and neural 
plasticity within the networks surrounding the lost tissue (Wieloch & Nikolich, 
2006).  
The goal of neuroprotection interventions is to limit the infarct size by targeting the 
acute cellular and molecular processes of the progressing ischemia (i.e., processes 
occurring within minutes to hours after the insult (Fagan, Hess, Hohnadel, Pollock, 
& Ergul, 2004)). Rehabilitation interventions instead aim to enhance recovery by 
restoring neural functionality during the subacute (i.e., hours to days after the insult 
(Fagan et al., 2004)) and chronic phases (i.e., days to months after the insult (Fagan 
et al., 2004)) (Gladstone, Black, & Hakim, 2002; Lee, Zipfel, & Choi, 1999; 
Moretti, Ferrari, & Villa, 2015). Optimal recovery, though, is difficult to achieve 
due to the complexity and heterogeneity of ischemic stroke and the lack of monitor-
ing methods that are able to properly determine the degree of recovery (Krakauer, 
2006). 
Microelectrode arrays (MEAs) inserted in the brain enable direct analysis of the 
electrophysiological characteristics of the neural tissue and may therefore provide 
novel insight into ischemic stroke (Jensen, Rousche, & Chiganos, 2006). This can be 
done by monitoring both the progression and extent of tissue loss and the functional 
state of the non-injured brain following the ischemic stroke and during recovery. 
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MEAs may also assist in elucidating the underlying mechanisms of neuroprotection 
and rehabilitation interventions.  
The focus of this thesis was therefore to study how MEAs may be utilized to inves-
tigate the ischemic brain, while testing novel approaches for neuroprotection and 
rehabilitation interventions. 
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CHAPTER 2. BACKGROUND 
This chapter first introduces the pathophysiological processes of ischemic stroke and 
how these are expressed throughout the ischemic territory (see Sec. 2.1). Second, the 
brain's innate neuroprotective and recovery mechanisms (see Sec. 2.2) and the ap-
proaches and targets of ischemic stroke interventions are reviewed (see Sec. 2.3). 
Finally, because the use of MEAs is a new approach to investigate ischemic stroke, 
it must be tested in animal models. Thus, the chapter is concluded by describing 
various aspects of experimental animal models (see Sec. 2.4).    
2.1. ISCHEMIC STROKE 
Ischemic stroke leads to a decline in blood flow, causing metabolic and biological 
functions to become suppressed within the neural tissue supplied by the affected 
blood vessel(s). The severity of the ischemic impact and the cascade of pathological 
processes (denoted as the ischemic cascade) vary throughout the affected tissue.    
2.1.1. THE ISCHEMIC TERRITORY 
The concept of viability thresholds utilizes critical blood flow levels to differentiate 
and demarcate the ischemic territory into regions with different levels of suppressed 
metabolic and biological function (Hossmann, 2012). The upper viability threshold 
is defined by the blood flow level at which the neural tissue experiences electrical 
failure, whereas the lower viability threshold is defined by the level at which cell 
membrane failure occurs (Hossmann, 1994).  
The most heavily impacted region is the ischemic core, where cells are mortally 
injured within minutes due to blood flow levels below the lower viability threshold 
(see Fig. 2-1). The least affected region is the benign oligemia, where no functional 
or metabolic disturbances are apparent, because the blood flow levels range between 
normal unobstructed blood flow and the upper viability threshold (T. H. Murphy & 
Corbett, 2009). Intermediately, the penumbra is located. This region receives suffi-
cient blood to initially uphold metabolic activity to preserve the morphological 
properties of the tissue (Astrup, Siesjo, & Symon, 1981; Astrup, Symon, Branston, 
& Lassen, 1977; Lo, 2008). The blood supply shortage within the penumbra is high-
est closest to the ischemic core and decreases towards the healthy neural tissue be-
cause this region may be supplied by other artery systems that may not be affected 
by the stroke (T. H. Murphy & Corbett, 2009).  
Initially, the lower viability threshold is approximately 15% of the normal unob-
structed blood flow level, but it will increase over time, particularly within the pe-
numbra, due to a progressively increasing mismatch between the blood flow and 
metabolism caused by the ongoing ischemic cascade (Hossmann, 2012). As a result, 
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the ischemic core will over time expand into the penumbra (Dirnagl, Simon, & 
Hallenbeck, 2003; Kunz et al., 2010). 
 
Figure 2-1. The ischemic territory as demarcated by the viability thresholds. Adapted from 
(T. H. Murphy & Corbett, 2009). 
2.1.2. EVENTS OF THE ISCHEMIC CASCADE 
The ischemic cascade involves a complex series of pathological processes that 
evolve over time and space following ischemic stroke and that are dependent on the 
severity and location of the ischemia as well as the cellular context of the affected 
tissue (Wieloch & Nikolich, 2006). 
Excitotoxicity 
Excitotoxicity refers to a process where excessive amounts of excitatory neurotrans-
mitter (predominately glutamate) accumulate in the extracellular space (Choi, 1988). 
This accumulation is a consequence of the excessive neurotransmitter release of 
cells that become necrotic and impeded re-uptake due to energy failure (Mehta, 
Manhas, & Raghubir, 2007). Excitotoxicity results in an excessive influx of Ca
2+
 
(denoted Ca
2+
 overload), which triggers nuclear and cytoplasmatic processes that 
cause membrane degradation, inflammatory responses and apoptosis (Sattler & 
Tymianski, 2001; Woodruff et al., 2011). At the same time, swelling of the cell 
occurs due to Na
+
 and Cl
-
 influx with relatively little K
+ 
efflux, which leads to the 
passive transport of water into the cell (Endres et al., 2008).  
Peri-infarct depolarization 
Peri-infarct depolarizations (PIDs) are waves of depolarizations that spread from 
the ischemic core and outwards throughout the penumbra (Lauritzen, 1994; Risher, 
Ard, Yuan, & Kirov, 2010). The neural networks of the penumbra may experience 
multiple depolarizations and repolarizations due to the excessive amounts of neuro-
transmitter within the extracellular space (Dirnagl, Iadecola, & Moskowitz, 1999). 
This leads to elevated energy consumption within the tissue, and the ischemic core 
has been documented to expand following each PID (Doyle, Simon, & Stenzel-
poore, 2008; Strong et al., 2007). For example, Hartings et al. (Hartings, Rolli, Lu, 
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& Tortella, 2003) showed that PIDs predominantly occur within the first 24 hours 
following ischemic stroke in a rat model. The highest PID incidence rates were 
concentrated around two phases, i.e., the initial ischemic insult (0 – 2 hours after 
ischemic stroke) and the period of infarct maturation (8 – 18 hours after ischemic 
stroke). 
Inflammation 
Pro-inflammatory mediators are secreted by various cell populations (e.g., endothe-
lial cells, astrocytes, microglia, and neurons) within the ischemia-affected neural 
tissue following the insult. The mediators include both destructive (e.g., toxic me-
tabolites and enzymes) and protective factors (e.g., erythropoietin). As a conse-
quence, the overall role of the inflammatory factors may differ over time and space 
(Woodruff et al., 2011). Thus, protective and regenerative activities occur days to 
weeks after the ischemic insult, whereas the blood-brain barrier may rapidly be-
come dysfunctional, resulting in poor perfusion within the penumbra (Endres et al., 
2008). 
Necrosis 
Necrosis is an uncontrolled form of cell death where the cellular content is extruded 
as the cell disintegrates, thereby potentially inflicting damage to surrounding cells 
due to excitotoxicity and the triggering of inflammation. Necrosis is a result of ener-
gy failure due to the blocked blood supply, and necrotic cells first undergo swelling 
followed by the disruption of the nuclear, organelle, and plasma membranes and 
structure, and then the cells shrink and disintegrate (Neumar, 2000). 
Apoptosis 
Apoptosis is a programmed form of cell death where the cells are systematically 
disassembled rather than disintegrated. Apoptosis results in less inflammation and 
less release of genetic material compared to necrosis (Lee et al., 1999). As result, the 
effect on the surrounding tissue is minimal (Neumar, 2000). The severity and dura-
tion of the ischemia determines whether the cells undergo rapid necrosis or slower-
progressing apoptosis (Mehta et al., 2007). Accordingly, apoptosis is the predomi-
nant form of cell death within the penumbra (Broughton, Reutens, & Sobey, 2009). 
Apoptosis is triggered by factors such as free radicals, DNA damage, and mitochon-
drial injury (Dirnagl et al., 1999) and can be induced by excitotoxicity, Ca
2+
 over-
load and oxidative stress (Mehta et al., 2007). One of the most distinctive markers of 
apoptosis is the activation of caspases (a group of protease enzymes), which play an 
essential role in the later stages of programmed cell death (Lee et al., 1999). 
2.1.3. JANUS-FACED NATURE OF THE ISCHEMIC CASCADE 
To further complicate the ischemic stroke pathology, several of the processes that 
occur following the ischemic insult mediate cell death during the acute phase but 
may promote recovery within the penumbra at a later point in time (Lo, 2008). For 
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example, excessive amounts of glutamate are detrimental in the acute phase by me-
diating excitotoxicity, but are suggested to promote the endogenous neurogenesis 
that occurs later on (Arvidsson, Kokaia, & Lindvall, 2001; Bernabeu & Sharp, 
2000). Similarly, apoptosis induces cell death, but at the same time inhibits inflam-
mation (Zipfel, Babcock, Lee, & Choi, 2000). Thus, the same element of ischemic 
stroke (e.g., molecules, signaling pathways or cells) will engage in destruction or 
repair, depending on factors such as the severity and location of the ischemia as well 
as the cellular context of the affected tissue and the elapsed time from the ischemic 
insult (Endres et al., 2008; Wieloch & Nikolich, 2006). 
2.1.4. SPATIAL AND TEMPORAL PROGRESSION OF THE ISCHEMIC 
CASCADE 
The stereotyped progression of the ischemic cascade initial involves energy failure 
due to the blocked blood supply. This results in necrosis that leads to excitotoxicity 
within the neighboring tissue and subsequently PIDs. Secondary damage occurs as 
inflammation develops within the affected tissue, and at the same time cell death 
occurs within cells that have been triggered to undergo apoptosis (see Fig. 2-2) 
(Endres et al., 2008). The ischemic cascade progresses rapidly following the ischem-
ic insult, and the neuroprotective potential is the largest within the first hour follow-
ing the stroke, where the penumbra constitutes up to 50% of the tissue directly in-
fluenced by the ischemia (Saver et al., 2010). From here on, the amount of salvagea-
ble tissue rapidly declines as the ischemic core progressively expands to include the 
penumbra until approximately 3 – 6 hours after the insult, when the ischemic core is 
close to its full extent (Hossmann, 2012). Apoptosis has, however, been shown to 
result in significant cell death in regions where reperfusion occurs. Thus, following 
reperfusion, the cells of the penumbra may recover the ability to generate action 
potentials for 24 – 72 hours, after which this ability is lost again and the cells under-
go apoptosis (Lee et al., 1999; Witte et al., 2000). This could likely be one of the 
key pathological mechanisms of cell death within the exterior part of the penumbra, 
where the cells are initially rescued by spontaneous recanalization or improvement 
of collateral blood flow (Witte et al., 2000).  
 
Figure 2-2. Conceptual illustration of the ischemic cascade. Adapted from (Endres et al., 
2008). 
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2.1.5. INDIRECT EFFECTS OF THE ISCHEMIC CASCADE – DIASCHISIS 
The brain constitutes a complex network of multiple and intricate neural connec-
tions, and ischemic stroke exerts wide effects on the neural networks and their 
communication. The direct consequences of the ischemic insult are observed within 
the ischemic core and penumbra, whereas indirect effects occur within the surround-
ing tissue (Witte et al., 2000). Diaschisis describes neurophysiological changes in 
remote brain areas that are not directly affected by the ischemia (Witte et al., 2000). 
Instead the changes within the remote areas are a direct inhibitory or excitatory 
effect of the injuries within the ischemic tissue. Diaschisis occurs early after stroke 
(within minutes), and the etiologies can broadly be split into the following catego-
ries: 1) brain edema, 2) inflammation, 3) changes that are consequences of the 
spreading depression, and 4) changes in projection areas (Carrera & Tononi, 2014; 
Witte et al., 2000). For example, many studies on humans and animals have demon-
strated increased responses in the contralateral homotopic region to the ischemia-
affected neural networks (Carrera & Tononi, 2014). Mohajerani et al. (Mohajerani, 
Aminoltejari, & Murphy, 2011) attributed this increased excitability to the loss of 
inhibition exerted by the ischemic hemisphere via the transcallosal pathways. 
2.2. THE BRAIN'S OWN DEFENSE AGAINST ISCHEMIC STROKE 
2.2.1. ENDOGENOUS NEUROPROTECTION 
Endogenous neuroprotective mechanisms occur during the acute phase to prevent 
cell death as a result of the progressing ischemic cascade (see Fig. 2-3) (Auriel & 
Bornstein, 2010). For example, anti-excitotoxic, anti-inflammatory, and anti-
apoptotic mechanisms have been found that can protect the neural tissue from detri-
mental damage while the ischemic cascade progresses (Dirnagl et al., 2003). The 
anti-excitotoxic mechanism was found to upregulate inhibitory neurotransmitters 
and alter the composition of the neurotransmitter receptors in response to NMDA-
receptor activation (Heurteaux, Lauritzen, Widmann, & Lazdunski, 1995). 
2.2.2. RECOVERY MECHANISMS 
Recovery of behavioral function (e.g., motor function) occurs after ischemic stroke 
(Edward Taub, Uswatte, & Elbert, 2002) and is most marked during the initial 30 
days, but it progresses for at least six months, although with less pronounced gains 
during this period (see Fig. 2-3) (Duncan, Min Lai, & Keighley, 2000). The initial 
loss of behavioral function is a result of both the direct and indirect effects of the 
ischemic stroke, i.e., 1) cell death in the ischemic core, 2) cell malfunction and aber-
rant neurotransmission due to altered spine morphology in the penumbra, and 3) 
diaschisis in remote functionally connected regions (Witte et al., 2000).  
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Neural repair and reorganization 
Within the surviving penumbral tissue and the benign oligemia, the resolution of 
diaschisis and mechanisms of cell repair occur first, followed by functional cell 
plasticity and, at a later point in time, neuroanatomical plasticity, resulting in the 
formation of new neural connections (Wieloch & Nikolich, 2006). The neural repair 
and reorganization of cells is facilitated by the stimulation of anabolic processes via 
growth-promoting factors (e.g., survival, repair, and plasticity genes) that are upreg-
ulated twice within the first 24 hours after ischemic stroke (directly after ischemic 
stroke and 9 - 24 hours after ischemic stroke) and succeeded by a longer period of 
expression within the first week after the ischemic insult (Küry, Schroeter, & Jander, 
2004; Rickhag et al., 2006). Subsequently, growth-inhibitory genes are upregulated, 
thereby potentially regulating the efficiency of the neural plasticity by restricting 
outgrowth and repelling sprouting axons (T. H. Murphy & Corbett, 2009; Wieloch 
& Nikolich, 2006). During this period, the repaired penumbra and non-ischemic 
neural networks surrounding the lesion as well as the homotopic contralateral neural 
tissue initially become hyperexcitable, most likely due to deafferentation 
(Buchkremer-Ratzmann & Witte, 1997; Wieloch & Nikolich, 2006). In these hyper-
excitable tissues, long-term potentiation (LTP) is enhanced, the number of GABAA 
receptors is lowered, and the number of NMDA receptors is increased, causing ax-
onal sprouting to occur (Hagemann, Redecker, Neumann-Haefelin, Freund, & Witte, 
1998; Jones & Schallert, 1992; Qu et al., 1998; Witte et al., 2000). As such, recovery 
is mediated via reorganization of the repaired penumbra and the functionally con-
nected non-ischemic tissue, whereby these neural networks take over the function of 
the ischemic tissue (R J Nudo, Plautz, & Frost, 2001). The most rapid behavioral 
improvements (within the first few days after ischemic stroke) have been suggested 
to be due to the activation/strengthening of the redundant silent neural connections 
(denoted as silent pathways) (Dancause & Nudo, 2011; Metz, Antonow-Schlorke, & 
Witte, 2005). 
Neurogenesis 
The adult brain is continuously generating new neurons (Ming & Song, 2011). Neu-
rogenesis occur in the subventricular zone and the subgranular zone of the dentate 
gyrus and has been shown to increase following ischemic stroke in rats (Jin et al., 
2001). For example, neural stem cells have been shown to migrate into the ischemic 
striatum following middle cerebral artery occlusion (MCAO), where they express 
markers of developing and mature cells similar to those that were lost due to the 
ischemic stroke (Arvidsson, Collin, Kirik, Kokaia, & Lindvall, 2002). The fraction 
of dead cells that are replaced is, however, minimal (Arvidsson et al. (Arvidsson et 
al., 2002) estimated that 0.2% of the dead cells were replaced at 6 weeks), and stem 
cells that are recruited to damaged regions either undergo apoptosis or form mature 
neurons that survive for some months (Thored et al., 2006). This failure in long-term 
survival is presumably due to the lack of trophic support and functional neural con-
nections (Arvidsson et al., 2002). Therefore, it is not yet firmly established whether 
neurogenesis can contribute to recovery. 
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Figure 2-3. Conceptual illustration of the ischemic cascade, endogenous neuropro-
tection, and recovery mechanisms (e.g., neural repair, reorganization, and neuro-
genesis). Adapted from (Endres et al., 2008). 
2.3. INTERVENTIONS TO COUNTERACT ISCHEMIC STROKE 
As discussed in Section 2.2, the recovery from ischemic stroke is dependent on the 
extent of cell preservation in the acute phase and the repair of damaged neural tissue 
and engagement of neural networks that can help compensate for the lost brain func-
tions during the subacute and chronic phases (Wieloch & Nikolich, 2006). The ulti-
mate goal of ischemic stroke interventions is to restore the behavioral function and 
neural morphology to what was in place prior to the ischemic insult to achieve true 
recovery. In reality, it is not possible today to obtain 100% true recovery, and in-
stead recovery occurs through altered behavior and new neural response strategies 
provided by the reorganization of the preserved neural tissues, i.e., behavioral com-
pensation (M. F. Levin, Michaelsen, Cirstea, & Roby-Brami, 2002; M. Levin, 
Kleim, & Wolf, 2009; Metz et al., 2005; Whishaw, 2000). 
2.3.1. NEUROPROTECTION INTERVENTIONS 
Neuroprotection interventions target the ischemic cascade to block the pathological 
processes and prevent cell death (Auriel & Bornstein, 2010). Pharmacological inter-
ventions have targeted various mechanisms including excitotoxicity, calcium influx, 
nitric oxide production, inflammatory reactions and apoptosis to achieve neuropro-
tection (Moretti et al., 2015). Many of these pharmacological interventions have 
been applied with success in animal models, but later results from clinical trials have 
been discouraging (Dirnagl et al., 1999; Ginsberg, 2008; Kahle & Bix, 2012; Lo, 
2008). It has been suggested that the negative results may be explained by the inter-
ventions only targeting one of the multiple pathophysiological pathways, thereby 
rendering them very sensitive to proper treatment time (Fisher et al., 2009; 
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Gladstone et al., 2002; STAIR, 1999). Hypothermia is one of the only interventions 
that has shown promising results, as it targets a wide range of mechanisms including 
excitotoxicity, apoptosis and inflammation (van der Worp, Sena, Donnan, Howells, 
& Macleod, 2007; Yenari & Han, 2012). Recently, low-frequency electrical stimula-
tion (lf-ES) has been tested as an alternative neuroprotection intervention and was 
found to trigger several neuroprotective mechanisms that may diminish behavioral 
deficits, reduce apoptotic and necrotic cell death, block microglial activation, and 
promote angiogenesis (Baba et al., 2009; Plow & Machado, 2013). 
2.3.2. REHABILITATION INTERVENTIONS 
Interfering with neural plasticity can either block or enhance reorganizational pro-
cesses, and increased functional reorganization following ischemic stroke has been 
associated with behavioral recovery (Randolph J Nudo, Wise, Sifuentes, & Milliken, 
1996). Behavioral experience has been shown to be a potent modulator of functional 
reorganization and repetition and temporal coincidence, as apparent when repetitive-
ly performing skilled movements like this induces plastic changes (denoted hebbian 
plasticity) (Hummel & Cohen, 2005; Randolph J. Nudo, 2013). An important con-
cept of reorganization (e.g., observed in the motor cortex) relates to specific func-
tions having multiple and overlapping representations that are distributed within the 
neural networks and are highly interconnected (Bütefisch, 2004). Altering the 
strength of these connections via intrinsic and extrinsic stimuli facilitates the reor-
ganization and acquisition of novel behavioral patterns (Randolph J. Nudo, 2013). 
As such, functions that are lost following ischemic stroke are believed to be recov-
ered through reorganization within closely related networks, which may also be 
located within the homotopic contralateral cortex (Dancause & Nudo, 2011; Kopp et 
al., 1999). The most successful recovery is, however, thought to occur in individuals 
in whom reorganization has mostly taken place in the ischemic hemisphere, whereas 
bilateral cortical reorganization, typically after larger strokes, results in less com-
plete recovery (Cramer, 2008; Ward, Brown, Thompson, & Frackowiak, 2003).    
The rehabilitation of motor function has been investigated while using various forms 
of functional retraining to recover the otherwise lost function (Dancause & Nudo, 
2011). In both animals and humans, repetitive-training protocols and constraint-
induced movement therapy (CIMT) have been used and shown to improve the motor 
function and result in cortical reorganization (Liepert et al., 1998; Randolph J Nudo 
et al., 1996; E Taub et al., 1993). This use-dependent plasticity has been shown to be 
facilitated or inhibited by excitability-enhancing (Butefisch et al., 2002; Feeney, 
Gonzalez, & Law, 1982) or excitability-reducing pharmacological agents (Blin et 
al., 2001). Direct or indirect electrical and transcranial magnetic stimulation has also 
been documented to improve motor function when combined with functional retrain-
ing during the chronic phase of ischemic stroke (Hummel & Cohen, 2005). 
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2.3.3. TIMING OF REHABILITATION INTERVENTIONS 
In relation to the onset time of rehabilitation, a critical period where the rehabilita-
tion may be especially efficient due to a favorable interplay between growth-
promoting factors (i.e., proteins and genes) and growth-inhibitory factors has been 
postulated (T. H. Murphy & Corbett, 2009). In rat models of ischemic stroke, this 
critical period is located approximately 5 to 14 days after ischemic stroke 
(Biernaskie, Chernenko, & Corbett, 2004). Intensive rehabilitation or forced use 
initiated before the critical period has been shown to result in less recovery of be-
havioral function and enlargement of the ischemic territory, potentially due to exces-
sive energy demands (Bland et al., 2000; Humm, Kozlowski, James, Gotts, & 
Schallert, 1998; Kozlowski, James, & Schallert, 1996). Human studies have provid-
ed similar results, supporting the existence of a critical period following ischemic 
stroke (Horn et al., 2005; Salter et al., 2006) and indicating that very early and inten-
sive rehabilitation can lead to worse outcomes (Dromerick et al., 2009, 2015). 
Interference with homeostatic plasticity mechanisms is presumed to be accountable 
for some of the detrimental effects of very early and intensive rehabilitation (T. H. 
Murphy & Corbett, 2009). Conceptually, homeostatic plasticity defines mechanisms 
that ensure that neurons receive an adequate amount of neural input. As such, home-
ostatic mechanisms seek to restore a certain level of synaptic activity within the 
neural networks by acting as a negative feedback loop (Turrigiano & Nelson, 2004). 
During recovery, homeostatic mechanisms presumably stabilize the interrupted 
synaptic activity originating from the infarcted tissue by 1) resetting the activity 
levels of specific neurons, 2) forming new connections, and/or 3) changing the activ-
ity at the already existing synapses, thereby possibly unmasking silent pathways (T. 
H. Murphy & Corbett, 2009). In rodent models of ischemic stroke, homeostatic 
plasticity has been attributed to the expanded and less-specific receptive fields as 
well as the increased spontaneous activity occurring within the first week following 
the ischemic insult (Schiene et al., 1996; Winship & Murphy, 2008). 
2.4. EXPERIMENTAL ANIMAL MODELS OF ISCHEMIC STROKE 
The complexity of ischemic stroke and subsequent recovery calls for the use of large 
patient groups when performing clinical research to avoid the confounding effects of 
disease diversity (Bacigaluppi, Comi, & Hermann, 2010a). Because of these chal-
lenges, experimental animal models that enable larger degrees of control and moni-
toring of physiological variables are extensively used within ischemic stroke re-
search. 
Different stroke models have been developed (i.e., focal/global ischemia and transi-
ent/permanent occlusion) and applied in different animal species (including higher-
order primates (Randolph J Nudo et al., 1996; Plautz et al., 2003), rodents 
(Biernaskie & Corbett, 2001; Reglodi, Tamas, & Lengvari, 2003), and pigs (Sakoh, 
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Rohl, et al., 2000; Sakoh, Østergaard, et al., 2000)). The majority of the ischemic 
stroke models are designed for use in rodents, and rats have especially been exten-
sively utilized (Durukan & Tatlisumak, 2007). Rats have a physical size that allows 
for reasonably easy monitoring of their physiological parameters, and several meth-
ods of stroke induction may be applied due to the vascular structures of the rat 
(Mhairi Macrae, 1992). Finally, the low cost and greater acceptability from ethical 
perspectives facilitate the use of rodents in early investigations that seek to establish 
the effects of novel ischemic stroke interventions or investigate physiological mech-
anisms (Durukan & Tatlisumak, 2007). The physiological characteristics of primates 
and pigs, however, have a larger similarity to humans (e.g., a gyrencephalic brain), 
and as such they would be highly suited for use at later phases (Traystman, 2003). 
2.4.1. ISCHEMIC STROKE INDUCTION METHODS 
Several stroke induction methods exist, and the main objective for all is to generate 
a reproducible infarct with a minimum of surgical intervention (Carmichael, 2005). 
The following provides an overview of the focal ischemic stroke models, as these 
may be used to induce an ischemic stroke that is close to the size of a survivable 
human stroke (i.e., strokes that affect 5 – 15% of the hemisphere) (T. H. Murphy & 
Corbett, 2009). These methods primarily target the middle cerebral artery (MCA) 
and lead to deficits in motor and sensory functions (Moretti et al., 2015; Traystman, 
2003). The most commonly used methods are described below (Bacigaluppi, Comi, 
& Hermann, 2010b; Carmichael, 2005; Durukan & Tatlisumak, 2007; Mhairi 
Macrae, 1992; Sicard & Fisher, 2009; Traystman, 2003). 
Transection method 
Craniectomy 
Craniectomy may be necessary, but the orbital route to MCAO is preferred 
because this is a less traumatic procedure 
Procedure Electrocauterization of vessel(s) 
Transient occlusion No 
Permanent occlusion Yes 
Tissue damage Lesion location, size and severity are dependent on the site of ligation 
Advantages 
High correlation between the area of reduced blood flow and the area of 
neuropathological injury 
Disadvantages 
Highly invasive 
Requires extensive surgical skills 
Ligation method 
Craniectomy 
Craniectomy may be necessary, but the orbital route to MCAO is preferred 
because this is a less traumatic procedure 
Procedure Ligation of vessel(s) by use of microclips or ligature snares 
Transient occlusion Yes 
Permanent occlusion Yes 
Tissue damage Lesion location, size and severity are dependent on the site of ligation  
Advantage 
High correlation between the area of reduced blood flow and the area of 
neuropathological injury 
Disadvantage Highly invasive 
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Requires extensive surgical skills 
Intraluminal occlusion method 
Craniectomy Not required 
Procedure 
A monofilament is maneuvered into the targeted vessel(s) to perform the 
occlusion 
Transient occlusion Yes 
Permanent occlusion Yes 
Tissue damage Lesion size 5 - 50% of hemisphere 
Advantages 
Reproducible MCA territory infarcts 
Large penumbra shortly after MCA occlusion 
Minimal invasiveness 
Disadvantages 
Lesion size is often larger than in clinical studies 
Vessel rupture during insertion of filament 
Thromboembolic method 
Craniectomy Not required 
Procedure 
Injection of non-biological microspheres or artificially clotted blood into 
circulation 
Transient occlusion 
The thromboembolisms that occur after the injection of artificially clotted 
blood may undergo spontaneous reperfusion 
Permanent occlusion Yes, when using non-biological microspheres 
Tissue damage Widespread and multifocal cerebral ischemia 
Advantages Minimal invasiveness and close resemblance to human stroke 
Disadvantages 
Minimal control of the ischemia 
Spontaneous reperfusion may occur 
Photothrombosis method 
Craniectomy Not required but may ease the illumination procedure 
Procedure 
Illumination of a photosensitive dye that has been injected into the circula-
tion. Thromboembolic ischemia occurs within the tissue supplied by the 
illuminated blood vessel(s) 
Transient occlusion No 
Permanent occlusion Yes 
Tissue damage Localized and fairly demarcated thromboembolic ischemia  
Advantages 
Lesion size, location and severity are highly controllable and result in 
reproducible infarcts 
Disadvantages 
Small penumbral region 
May result in vasogenic edema and blood-brain barrier breakdown 
Endothelin-1 method 
Craniectomy Required 
Procedure 
Injection of endothelin-1 results in the vasoconstriction of cerebral vessels 
in the region of injection 
Transient occlusion Yes 
Permanent occlusion No 
Tissue damage Similar to ligation methods 
Advantages 
Gradual reperfusion 
Control over duration and location of ischemia  
Disadvantages 
The dose of endothelin-1 needs to be carefully standardized to assure proper 
control over the duration of the decreased blood flow 
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2.4.2. MONITORING METHODS 
Different monitoring methods have been used in experimental studies to evaluate the 
progression of ischemic stroke and the effects of ischemic stroke interventions. The 
methods can roughly be split into three groups with their individual focuses: 1) 
pathological consequences of ischemic stroke, 2) neurophysiological consequences 
of ischemic stroke, and 3) behavioral and functional consequences of ischemic 
stroke (Durukan & Tatlisumak, 2007; Sicard & Fisher, 2009). The methods for the 
assessment of the pathological and behavioral and functional consequences of is-
chemic stroke are by far the most commonly utilized (Kahle & Bix, 2012). 
Assessment of the pathological consequences of ischemic stroke 
Methods for assessing the pathological consequences of ischemic stroke, such as 
histological analysis and magnetic resonance imaging (MRI), seek to directly quan-
tify the pathological impact of the ischemic insult on the brain. Histological analysis 
may be used to quantify the infarct size or investigate more subtle morphological 
and chemical changes (Sicard & Fisher, 2009). MRI may be used to detect the is-
chemic lesion (denoted as diffusion-weighted imaging (DWI)) and the hypoperfused 
region (denoted as perfusion-weighted imaging (PWI)) (Neumann-Haefelin et al., 
1999). Reliable quantification of the histological infarct volume is difficult to 
achieve until 24 hours after the ischemic insult (Liu, Zhen, Meloni, Campbell, & 
Winn, 2009), whereas MRI can be used to investigate the lesion-induced changes 
within minutes of injury (Durukan & Tatlisumak, 2007). One drawback is that the 
pathological assessment has been shown to not always correlate well with the behav-
ioral improvements and should therefore be combined with behavioral assessment 
(Cheng, Al-Khoury, & Zivin, 2004; Hunter, Mackay, & Rogers, 1998). 
Assessment of the neurophysiological consequences of ischemic 
stroke 
Methods as electroencephalography (EEG), voltage-sensitive dye imaging (VSDI), 
electrophysiological recording and microstimulation mapping by use of MEAs allow 
for direct evaluation of the neurophysiological aspects of the ischemia-affected brain 
(Durukan & Tatlisumak, 2007). These methods provide information about the elec-
trophysiological state of the brain following ischemic stroke, and the plasticity 
changes that occur following ischemic stroke have been shown to be related to the 
behavioral function of the subject (Dancause & Nudo, 2011). MEAs can be used to 
record the electrophysiological properties of the neural networks with a high spatial 
and temporal resolution (M. A. L. Nicolelis, 2009) and can be used to record over 
long periods of time (i.e., up to several months) (Vetter, Williams, Hetke, 
Nunamaker, & Kipke, 2004). As such, MEAs have previously been used in a rat 
model of acute ischemic stroke to perform preliminary investigations on the ische-
mia-affected motor cortex (Jensen et al., 2006). 
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Assessment of the behavioral and functional consequences of ischem-
ic stroke 
The most frequently used methods for functional and behavioral assessment are 
sensorimotor function tests, as the experimentally induced ischemia results in these 
deficits (Kahle & Bix, 2012; Schaar, Brenneman, & Savitz, 2010). Cognitive tests 
may also be used, as learning and memory impairments are common after experi-
mentally induced ischemic stroke (Schaar et al., 2010). Sensorimotor function tests 
generally focus on detecting and quantifying asymmetries that occur after unilateral 
ischemic stroke (Hua et al., 2002). Tests of sensorimotor function in rodents assess 
the deficits by, for example, quantifying 1) the ratio of the uses of the affected limb 
and the non-affected limb (e.g., Cylinder test and Reaching/Grasping tests), 2) the 
number of faults made during the uses of the affected limb and the non-affected limb 
(e.g., Rung walking, Grid walking, Beam walking, and Reaching/Grasping tests), 
and 3) the rate and total number of successful executions of a task (e.g., Reach-
ing/Grasping tests) (Schaar et al., 2010). Composite tests (e.g., the Modified Neuro-
logical Severity Scores (mNSS)) rate the neurological function of the animal based 
on a series of tests (i.e., motor, sensory, reflex and balance tests) and therefore have 
the ability to assess multiple deficits (Schaar et al., 2010). Sensorimotor function 
tests that assess similar deficits exist in non-human primate models of ischemic 
stroke (Cook & Tymianski, 2012). A drawback of the sensorimotor function tests is 
that they do not exhibit similar rates of recovery following ischemic stroke (Hunter 
et al., 2000), as they are sensitive to measuring deficits dependent on the particular 
areas of damage (Schaar et al., 2010). Additionally, the majority of the methods only 
provide limited information on the movement pattern, and it is therefore unknown 
whether the animal uses an alternative movement strategy to accomplish the task 
goal (Krakauer, 2006). Whishaw (Whishaw, 2000) has, however, used video records 
to investigate movement patterns and found that the animals recovered to within 
10% of their healthy state success level on a skilled movement task. Nevertheless, 
from the video data it could be observed that the recovered performance on the task 
was mediated via altered movement patterns.  
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CHAPTER 3. HYPOTHESIS 
The large population of people suffering from impacts related to ischemic stroke 
calls for further research on understanding the pathophysiological mechanisms and 
neuroprotection and rehabilitation interventions. MEAs may be used to further in-
vestigate various aspects of ischemic stroke because the technique 1) may allow for 
the monitoring of the electrophysiological signals with high spatial and temporal 
resolution, 2) may be used to monitor the development of the ischemic stroke as 
well as the recovery processes from the acute to the chronic phase, and 3) may po-
tentially monitor both the progression and extent of tissue loss and the functional 
state of the non-injured brain following the ischemic stroke. The hypothesis of this 
Ph.D. thesis was therefore 
Utilizing microelectrode arrays to monitor intracortical electrophysiological sig-
nals will provide novel insight into ischemic stroke and can be a useful tool when 
testing novel approaches for neuroprotection and rehabilitation interventions. 
3.1. EXPERIMENTAL STUDIES 
Four experimental studies were designed to address the hypothesis, and each of 
them has resulted in a journal paper. The motivation for the individual studies and 
the experimental methods as well as the publication status of each paper is described 
in the following. The published paper(s) can be obtained from the respective jour-
nals. 
Study I: R. K. Nielsen, K. Yoshida, and W. Jensen, "Global and focal features ex-
tracted from intracortical multi-unit signals for investigation of electrophysiological 
changes in a rat model of ischemic stroke", (IN PREPARATION), 2016 
MEAs can be designed to meet the custom needs of each specific experiment. Fur-
thermore, the high spatial and temporal resolution of the MEA recordings results in 
large amounts of complex data and allows many forms of data analysis. However, to 
the best of the author's knowledge, no standardized MEA design or data analysis 
methods exist for use in ischemic stroke research. The objective of Study I was 
therefore to develop and test a novel MEA and data analysis techniques for use in 
the ischemic stroke model. 
Study II: R. K. Nielsen and W. Jensen, "Low-frequency Intracortical Electrical 
Stimulation Decreases Sensorimotor Cortex Hyperexcitability in the Acute Phase of 
Ischemic Stroke", IEEE Trans. Neural Syst. Rehabil. Eng., (ACCEPTED), 2016 
Study III: R. K. Nielsen and W. Jensen, "Low-frequency Intracortical Electrical 
Stimulation Impedes Spatial and Temporal Spreading Hyperexcitability in the Acute 
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Phase of Ischemic Stroke", IEEE Trans. Neural Syst. Rehabil. Eng., (UNDER RE-
VIEW), 2016 
Neuroprotection interventions that target a wide range of cell death mechanisms 
may have a high potential for successful translation into the clinical setting 
(Gladstone et al., 2002). Lf-ES of the ischemic brain may be one these interventions, 
but it has been used only sporadically in experiments (Baba et al., 2009; Plow & 
Machado, 2013). The objective of Studies II-III was to investigate the neuroprotec-
tive effect of lf-ES applied to the ischemic brain in the acute phase following is-
chemic stroke. Study II utilized a set of global features to characterize the global 
state of the cortical tissue following the ischemic insult, whereas Study III utilized a 
set of focal features to further investigate the spatio-temporal changes to the cortical 
tissue.    
Study IV: R. K. Nielsen, K. L. Samson, D. Simonsen, and W. Jensen, "Effect of 
Early and Late Rehabilitation Onset in a Chronic Rat Model of Ischemic Stroke — 
Assessment of Motor Cortex Signaling and Gait Functionality Over Time", IEEE 
Trans. Neural Syst. Rehabil. Eng., vol. 21, no. 6, pp. 1006-1015, 2013 
MEAs allow for the monitoring of the ischemic brain directly after the insult and 
into the chronic phase. Therefore, the MEA may be used to test the postulated exist-
ence of a critical period during which rehabilitation is especially efficient and de-
termine if rehabilitation prior to this period may exacerbate the injury (T. H. Murphy 
& Corbett, 2009). Thus, the objective of Study IV was to explore how the timing of 
rehabilitation onset affects the recovery of ischemia-affected neural networks and 
behavioral function within the subacute-chronic phase. 
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CHAPTER 4. EXPERIMENTAL METH-
ODOLOGIES 
The ischemic stroke model was based on male Sprague-Dawley rats and the photo-
thrombosis method because these animals are low-cost and the photothrombosis 
method is easy to control and results in reproducible ischemic strokes (see Sec. 
2.4.1). Additionally, preliminary data using this model existed (Jensen et al., 2006). 
To record the electrophysiological characteristics of the ischemic brain, the activity-
related neural responses of the sensorimotor cortex were investigated. This neural 
activity was correlated to a given event in all studies, i.e., either to sensory inputs 
artificially induced by sciatic nerve stimulation (Studies I-III) or to motor outputs to 
control the gait pattern (Study IV).   
A 28-channel intracortical MEA (IC MEA) with which an ischemic stroke could be 
induced within the center of the recording area was designed and utilized in the 
acute experiments (Studies I-III, see Fig. 4-3). This type of MEA design was pa-
tented by Rousche et al. (Rousche, Chiganos, & Jensen, 2009) but has to the best of 
the author's knowledge not previously been used in an experimental setting. A 16-
channel IC MEA design was instead used in the chronic experiment (Study IV, see 
Fig. 4-4).  
Novel analysis methods to quantify the neural activity were designed and used in the 
acute experiments (Studies I-III) with the aim of obtaining measures that reflect the 
spatial and temporal progression of ischemia. In the chronic experiment (Study IV), 
more conventional analysis methods, focusing on the neural activity obtained from 
individual electrodes, were used.  
Table 4-1 provides an overview of the experimental methodologies that were used in 
each study of the thesis. 
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Table 4-1 Overview of experimental methodologies 
Experimental protocol (Sec. 4.1) 
 Study I Study II Study III Study IV 
Animals 
Control group 
(six rats) 
Intervention group (nine rats)  
Control group (eight rats)  
Early-onset group (five rats)  
Late-onset group (four rats) 
Focus Methodology Neuroprotection Rehabilitation 
Phase of stroke Acute Acute Subacute-chronic 
Exp. timeline See Fig. 4-1 See Fig. 4-2 
 
Animal preparation (Sec. 4.2) 
 Study I Study II Study III Study IV 
IC MEA See Fig. 4-3 See Fig. 4-4 
Other devices Cuff electrode on right sciatic nerve 
Kinematic markers on right 
hindlimb 
 
Photothrombosis intervention (Sec. 4.3) 
 Study I Study II Study III Study IV 
Fiber optical 
probe 
φ = 1 mm, white light φ = 3 mm, white light 
Rose Bengal 
sodium salt 
Concentration: 20 mg dye/ml saline 
Injection dose: 0.3 ml/100 g body weight 
Injection time: 2 min 
Illumination time 30 min 
Stroke induction 
site 
Center of IC MEA (see Fig. 4-3) Rostrally to IC MEA (see Fig. 4-4) 
 
Interventions to counteract ischemic stroke (Sec. 4.4) 
 Study I Study II Study III Study IV 
Neuroprotection NA 
Low-frequency intracortical electrical 
stimulation (lf-ICES) 
NA 
Rehabilitation NA 
Beam traversals 
Treadmill walking 
 
Data acquisition (Sec. 4.5) 
 Study I Study II Study III Study IV 
IC recordings Sensorimotor cortex responses to sciatic nerve stimulation 
Sensorimotor cortex activity during 
treadmill walking 
IC microstimula-
tion mapping 
NA 
Visual assessment of motor re-
sponse 
Behavioral 
function 
NA 
Video recording of beam traversals 
and treadmill walking 
 
Data analysis (Sec. 4.6) 
 Study I Study II Study III Study IV 
IC recordings 
Global and 
focal neural 
response 
patterns 
Global neural 
response patterns 
 Focal neural 
response patterns 
 Neural response patterns for 
subgroups of electrodes with 
similar hindlimb association 
IC microstimula-
tion mapping 
NA Grouping of motor responses 
Behavioral 
function 
NA 
Foot drops per beam traversal 
COG of hindlimb during treadmill 
walking 
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4.1. EXPERIMENTAL PROTOCOL 
4.1.1. STUDIES I-III 
In total, 17 male Sprague-Dawley rats were included in studies I-III. The rats were 
assigned to either the Intervention group (i.e., nine rats receiving low-frequency 
intracortical electrical stimulation (lf-ICES) via the IC MEA) or the Control group 
(i.e., eight rats where the stroke was allowed to progress without any neuroprotec-
tion intervention). 
Two baseline recording sessions were performed prior to the photothrombosis inter-
vention (referred to as B1 and B2), and 15 recording sessions (referred to as P0 - 
P14) were conducted over a seven-hour period after the photothrombosis interven-
tion (see Fig. 4-1). For the Intervention group, the neuroprotection intervention was 
initiated directly after P0 and maintained for four hours, only being interrupted in a 
seven-minute period during the recording sessions. 
Figure 4-1. Timeline of the experiments conducted in Studies I-III. 
4.1.2. STUDY IV 
In total, nine male Sprague-Dawley rats were included in study IV. The rats were 
assigned to either the Early-onset group (five rats that initiated their rehabilitation 
training on day one after ischemic stroke) or the Late-onset group (four rats that 
initiated their rehabilitation training on day seven after ischemic stroke). 
Two baseline recording sessions were performed prior to the photothrombosis inter-
vention (referred to as B1 and B2), and seven recording sessions (referred to as D1 - 
D7) were performed during four weeks of rehabilitation (see Fig. 4-2). The rehabili-
tation training consisted of 3 x 1 min treadmill walking and 25 beam traversals five 
days per week and was similar for both groups. IC microstimulation mapping was 
performed just before recording session B1 and after recording session D7.   
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Figure 4-2. Timeline of the experiments conducted in Study IV. 
4.2. ANIMAL PREPARATION 
4.2.1. STUDIES I-III 
Studies I-III were carried out as acute (i.e., one-day) experiments, and the rats were 
anaesthetized throughout the experiment. A cuff electrode was implanted around the 
sciatic nerve of the right hindlimb and used to generate a sensory input that could be 
recorded by the 28-channel IC MEA that was inserted in the hindlimb input layer of 
the left sensorimotor cortex (see Fig. 4-3). 
Figure 4-3. Animal preparation for Studies I-III. 
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4.2.2. STUDY IV 
The animal experiments in Study IV were carried out as chronic (i.e., up to six 
weeks from the animal preparation to the end of the rehabilitation training) experi-
ments. A 16-channel IC MEA was chronically implanted in the sensorimotor cortex 
related to hindlimb function to record the neural activity. During the recordings, four 
markers were temporarily placed on the rats' right hindlimbs to obtain the kinematics 
of the hindlimb while the rats were walking on a motorized treadmill (see Fig. 4-4). 
Figure 4-4. Animal preparation for Study IV. 
4.3. PHOTOTHROMBOSIS INTERVENTION 
4.3.1. STUDIES I-IV 
The photothrombosis method, where illumination causes a reaction between the 
circulating blood and a photosensitive dye, was used to induce an ischemic stroke 
(Watson, Dietrich, Busto, Wachtel, & Ginsberg, 1985). A hollow tube (referred to as 
the guiding tube) was integrated into the IC MEA and provided access to the cortical 
surface for an optical probe (see Fig. 4-3 and Fig. 4-4) to illuminate the cerebral 
blood vessels. 
4.4. INTERVENTIONS TO COUNTERACT ISCHEMIC STROKE 
4.4.1. STUDY I 
No intervention to counteract ischemic stroke was applied in study I. 
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4.4.2. STUDIES II-III – NEUROPROTECTION INTERVENTION 
The neuroprotection intervention consisted of 23 min. sessions of lf-ICES applied 
simultaneously on all electrodes of the IC MEA. The stimulation was designed as 
cathodic-first, charge-balanced biphasic constant-current pulses (frequency = 2 Hz, 
pulse width = 0.2 ms, amplitude = 50 μA). The paradigm was based on observations 
from studies by Hess & Donoghue (Hess & Donoghue, 1996), Froc et al. (Froc, 
Chapman, Trepel, & Racine, 2000), and Baba et al. (Baba et al., 2009), where the 
first two induced long-term depression (LTD) using similar stimulation parameters 
and the last showed a neuroprotective effect of the stimulation. 
4.4.3. STUDY IV – REHABILITATION INTERVENTION 
The repetitive rehabilitation training consisted of 25 beam traversals and 3 x 1 min 
of treadmill walking per day for five days a week. The amount of training was a 
tradeoff between enabling a large number of repetitions while assuring consistency 
in the quality of the movement to induce hebbian plasticity (T. H. Murphy & 
Corbett, 2009; Woldag & Hummelsheim, 2002). As such, the level of training was 
chosen based on observations from pilot experiments where the performance de-
clined when the training was increased beyond the amount described above. 
4.5. DATA ACQUISITION 
4.5.1. STUDIES I-III 
IC recordings 
To assess the neural network functionality, a train of 240 electrical stimulation puls-
es was delivered to the cuff electrode (frequency = 2 Hz, pulse width = 0.1 ms, am-
plitude = 3 mA), and the evoked sensorimotor cortex responses were simultaneously 
recorded by the IC MEA. 
4.5.2. STUDY IV 
IC microstimulation mapping 
IC microstimulation mapping was performed to identify the IC MEA electrodes that 
were related to hindlimb function. Each electrode of the IC MEA was consecutively 
stimulated (frequency = 100 Hz, pulse width = 200 μs, amplitude range = 100 - 500 
μA, amplitude increment = 50 μA), and the motor responses were visually assessed. 
Behavioral function 
For each recording session, 20 beam traversals were conducted to quantify the rats' 
ability to perform a skilled movement, and 4 x 30 s of treadmill walking was per-
formed to analyze the kinematics of the affected hindlimb. 
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IC recordings 
To assess the neural network functionality, the neural activity of the sensorimotor 
cortex was recorded by the IC MEA during the treadmill walking. 
4.6. DATA ANALYSIS 
4.6.1. STUDIES I-III 
IC recordings 
The data analysis algorithms translated the neural activities obtained from the indi-
vidual electrodes into 2D maps describing the activity at various locations within the 
IC MEA recording area according to the metrics of distance. A set of global and 
focal features were extracted from the maps to characterize the progression of the 
electrophysiological changes over time and space. The global features were designed 
to provide information about the overall state of the neural tissue, and the focal fea-
tures were designed to provide information about spatio-temporal changes within the 
neural tissue (see Fig. 4-5). 
Figure 4-5. Steps of the IC recording data analysis that was conducted in studies I-
III. '*' Focal features VOLUME and AREA were computed for the highly active 
areas located at various distances from the site of the photothrombosis intervention. 
4.6.2. STUDY IV 
IC microstimulation mapping 
The motor responses were grouped into hindlimb, forelimb, and no-motor responses 
based on visual observations while performing the mapping. 
Behavioral function 
The average number of foot drops per beam traversal was computed to quantify the 
rats' ability to perform a skilled movement. The rat was placed on the broad end of a 
ledged beam, and it traversed the beam to reach a shelter on the narrow end of the 
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beam. The ledged beam was based on the one described by Schallert et al. 
(Schallert, Woodlee, & Fleming, 2002). For similar purposes, the centers of gravity 
(COG) for the toe, ankle joint, and knee joint markers were computed from video 
recordings of the rat walking on the treadmill. An abdomen marker was used as a 
point of reference during the calculation.  
IC recordings 
The data analysis algorithm grouped the neural activities obtained from the individ-
ual electrodes during the treadmill walking. The procedure was based on observa-
tions from the IC microstimulation mapping and resulted in three groups: 1) elec-
trodes that only elicited a hindlimb motor response prior to photothrombosis, 2) 
electrodes that elicited a hindlimb motor response both prior to and post photo-
thrombosis, and 3) electrodes that only elicited a hindlimb motor response post pho-
tothrombosis. Each group of electrodes was analyzed individually to investigate 
trends within the neural responses (see Fig. 4-6).   
Figure 4-6. Steps of the IC recording data analysis that was conducted in study IV. 
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CHAPTER 5. SUMMARY OF MAIN FIND-
INGS 
This thesis investigated the potential of MEAs to monitor electrophysiological sig-
nals with the aim of investigating ischemic stroke and developing novel approaches 
for neuroprotection and rehabilitation interventions. An overview of the objectives 
and main findings of the four studies are summarized in Table 5-1 and will be dis-
cussed in Chapter 6. 
Table 5-1 Overview of the objectives and main findings of the four studies 
 Objective Main findings 
Study I To develop and test a novel 
MEA and data analysis tech-
niques for use in the ischemic 
stroke model. 
1. The MEA and analysis methods allowed for 
detailed spatial and temporal characterization of 
the neural responses within the sensorimotor 
cortex. 
2. The MEA design did not allow for recording 
from the ischemic core. 
Study II To investigate the neuroprotec-
tive effect of lf-ES applied to 
the ischemic brain in the acute 
phase following ischemic 
stroke. 
1. Acute hyperexcitability occurred within the 
penumbra and/or lesser-affected neural networks 
following ischemic stroke. The hyperexcitability 
spread along a complex path influenced by time, 
space and neural connectivity. 
2. Lf-ES minimized the overall amount of hyper-
excitability and restricted its spread through the 
ischemia-affected neural networks. 
3. Lf-ES may potentially delay and reduce the 
spread of the progressively expanding ischemic 
core.  
Study III 
Study IV To explore how the timing of 
rehabilitation onset affects the 
recovery of ischemia-affected 
neural networks and behavioral 
function within the subacute-
chronic phase. 
1. Rehabilitation initiated seven days after is-
chemic stroke resulted in improved motor func-
tion and neural activity patterns with a large 
similarity to the healthy state compared to initiat-
ing rehabilitation on day one after ischemic 
stroke. 
2. The findings supported the existence of a 
critical period where rehabilitation may be more 
effective and facilitates a higher degree of recov-
ery. 
3. Initiating rehabilitation prior to the critical 
period may potentially exacerbate the ischemic 
injury. 
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CHAPTER 6. DISCUSSION 
6.1. METHODOLOGICAL CONSIDERATIONS 
In general, experimental and clinical studies differ on various aspects (see Table 6-
1). The failure of especially many neuroprotection interventions is attributed to the 
large diversity and heterogeneity in all aspects of clinical studies compared to exper-
imental studies (Fisher et al., 2009; STAIR, 1999; Traystman, 2003). 
Table 6-1 Overview of differences between experimental and clinical studies. 
Adapted from (Moretti et al., 2015; Sutherland et al., 2012; Willing, 2009) 
Experimental studies (animal) Clinical studies (human) 
1) Investigated population 
Highly controlled, homogeneous population 
Younger animals 
Limited comorbidities 
Previously untreated with drugs 
Gender: mostly male 
Variable, heterogeneous population 
Older patients 
Numerous comorbidities 
Previously treated with drugs 
Gender: male and female 
2) Nature of ischemic stroke 
Induced onset of ischemic stroke 
Uniform etiology 
Ischemic territory originating from MCAO 
Controlled occlusion duration 
Spontaneous onset of ischemic stroke 
Variable etiology 
Ischemic territory not restricted to MCA 
Variable occlusion duration 
3) Time window of intervention 
Control over intervention time window (usually early 
onset in studies on neuroprotection) 
Less control over intervention time window (usually 
delayed onsets of both neuroprotection and rehabilitation) 
4) Outcome measurements 
Infarct volume as primary outcome (in neuroprotective 
studies) 
Behavioral function  
Short follow-up time 
Behavioral function as primary outcome 
Long follow-up time 
 
 
In the present work, many of the characteristic differences between experimental 
and clinical studies were present. Because the focus of the work was on the design 
and testing of novel monitoring methods and ischemic stroke interventions, it was 
attempted to control as many parameters as possible. As such, it is believed that the 
present model can provide insight into injury and recovery mechanisms, but the 
clinical potential of the findings is still debatable, and therefore they should be in-
vestigated further by broadening the model. The following will elaborate on the 
methods that were used in the model and how they may be improved. 
6.1.1. THE RAT AS A MODEL OF ISCHEMIC STROKE 
Aging has been related to reduced angiogenesis and poor recovery of behavioral 
function following ischemic stroke in rats (Zhang et al., 2005), but contradictory 
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results have been reported when the infarct volume has been investigated (Durukan 
& Tatlisumak, 2007). For example, Duverger and MacKenzie (Duverger & 
MacKenzie, 1988) and Wang et al. (Wang, Wang, & Yang, 2003) found no correla-
tion between the age and infarct volume in rats, whereas Davis et al. (Davis, 
Mendelow, Perry, Chambers, & James, 1995) found that the infarct volume was 
larger in older rats, and Shapira et al. (Shapira, Sapir, Wengier, Grauer, & Kadar, 
2002) oppositely found that younger rats had a larger infarct volume. Studies in 
female rats have shown that ovarian hormones have a neuroprotective effect 
(Hoffman, Merchenthaler, & Zup, 2006), and hypertensive rats develop larger and 
less variable infarcts when subjected to intraluminal occlusion (Coyle, 1986). 
In the present work, male Sprague-Dawley rats were used in all experiments. The 
age of the rats ranged from 10 to 14 weeks, which corresponds to young adulthood 
when compared to human age (Sengupta, 2013), and at this age, the cortex of the rat 
has reached its adult size (Kolb & Tees, 1990). The rats did not have any underlying 
chronic diseases or genetic predisposition to certain diseases. To further test the 
results of the present work, the experiments should be replicated while including 
both female rats of varying ages and hypertensive rats. Furthermore, the Stroke 
Therapy Academic Industry Roundtable (STAIR) (Fisher et al., 2009; STAIR, 1999) 
emphasizes that at least one other species (preferably a gyrencephalic species) 
should also be used. 
6.1.2. INDUCTION OF ISCHEMIC STROKE 
Several methods for the induction of ischemic stroke exist, and each has its individ-
ual advantages and disadvantages (see Sec. 2.4.1). In the present work, the photo-
thrombosis method was used due to its high reproducibility. The method results in a 
well-demarcated infarct with a small penumbral region that rapidly reaches its full 
extent as microvascular occlusions occur throughout the illuminated area (Dietrich, 
Ginsberg, Busto, & Watson, 1986; Watson et al., 1985).  
Study I showed that the MEA did not record from the ischemic core or severely 
affected penumbra, as it was observed that the neural networks did not turn func-
tionally silent as the ischemic stroke progressed (Astrup et al., 1981, 1977). This 
observation indicates that the penumbral region may have been small and did not 
extend far from the site of the photothrombosis intervention. This may be a problem, 
as the penumbra is the main target of neuroprotection interventions to salvage neural 
tissue (STAIR, 1999). A modified version of the photothrombosis methods may help 
to circumvent this problem by inducing a ring-shaped ischemic infarct with a 're-
gion-at-risk' situated in the center of the ring (Wester, Watson, Prado, & Dietrich, 
1995). Within this region, spontaneous reperfusion (Hilger, Blunk, Hoehn, Mies, & 
Wester, 2004) and PIDs have been observed (Risher et al., 2010), and the pathologi-
cal mechanisms more closely resemble those of clinical stroke with a larger penum-
bra. Thus, applying this photothrombosis method to the current ischemic stroke 
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model may help to improve the clinical relevance of the model and allow for elec-
trophysiological monitoring of the neural networks that are directly damaged by the 
ischemic stroke (i.e., the neural tissue in the ischemic core and the penumbra).    
Furthermore, STAIR (Fisher et al., 2009; STAIR, 1999) emphasizes that both per-
manent and transient ischemic stroke models should be used for the evaluation of 
the neuroprotective potential of an intervention. A transient ischemia cannot be 
obtained with the photothrombosis method (see Sec. 2.4.1), and therefore another 
stroke induction method should be used when testing lf-ES in transient ischemia 
models. However, specific precautions should be taken when inducing transient 
ischemia, as the secondary damage following prompt reperfusion (e.g., as with the 
intraluminal or ligation stroke methods) does not resemble the secondary damage 
following gradually and prolonged reperfusion that may occur spontaneously or 
following recombinant tissue plasminogen activator (rtPA) intervention in the clini-
cal setting (Hossmann, 2012). Consequently, the endothelin-1 method may be more 
suitable for use in a transient ischemia model, as it results in gradual reperfusion 
(see Sec. 2.4.1). 
6.1.3. THE USE OF MICROELECTRODE ARRAYS 
MEAs may be custom-designed to meet the needs of a specific experiment. A dif-
ferent electrode layout and configuration of the MEA was used in Studies I-III 
compared to those in Study IV. These differences in MEA design reflected the 
availability of recording equipment and the progression in the expertise and 
knowledge of electrode manufacturing that was obtained during the work. Study IV 
was performed first, at a point in time where a recording system allowing for the 
recording of only 16 channels was available, whereas for Studies I-III, a recording 
system that allowed for the recording of more channels was available.    
However, one general disadvantage was that the guiding tube covered the area situ-
ated directly beneath it, thereby making it impossible to record from the neural tis-
sue in this region (see Fig. 4-3 and Fig. 4-4). Consequently, it was not possible to 
establish the distribution of the hindlimb motor and/or sensory function within this 
sensorimotor cortex region, and it was also impossible to monitor the ischemic core 
and directly estimate the severity of the insult. The guiding tube of the MEA is, 
however, believed to have been located in the center of the hindlimb area, as it 
was carefully placed by the use of a micromanipulator based on knowledge from 
prior microelectrode stimulation/recording studies (Neafsey et al., 1986; Welker, 
1976), transdural stimulation mapping studies (Fonoff et al., 2009), and histological 
studies (Paxinos & Watson, 2008). As described in Study I, it may be possible to 
both record and induce ischemic stroke within the same neural tissue if using a 
clear-transparent UV-curing biocompatible resin (e.g., Freeprint® splint, Detax 
GmbH & Co, Ettlingen, Germany) as a base for the MEA cast. 
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6.1.4. DATA ANALYSIS OF ELECTROPHYSIOLOGICAL RECORDINGS 
MEAs render it possible to utilize various data analysis methods to infer on the state 
of the brain. The most basic data analysis focuses on single-electrode data, but as 
brain functions (e.g., motor functions) are encoded by large populations of neurons, 
this approach means that information may be lost (Georgopoulos, Schwartz, & 
Kettner, 1986; M. A. Nicolelis, Ghazanfar, Faggin, Votaw, & Oliveira, 1997).  
In the present work, it was sought to characterize the changes within the entire rec-
orded region of the sensorimotor cortex rather than to investigate highly local 
changes on a single-electrode basis. The focal measures, which were developed and 
used in Study I and Study III (see Sec. 4.6.1), are believed to hold the largest po-
tential to characterize the progression of the ischemic stroke because these features 
provide information not only on the area-wise size and the magnitude of the neural 
response but also on the distance between the responding network and the ischemic 
core. As such, the results from the focal measures showed that the hyperexcitability 
progressed outward from the ischemic core over time. However, the focal measures 
did not provide any indication on whether the outward spread of the hyperexcitabil-
ity progressed along a specific direction away from the ischemic core (e.g., rostrally 
or laterally) or had an inclination towards occurring within another functional subre-
gion of the sensorimotor cortex (e.g., occurring within the forelimb area after injury 
in the hindlimb area). To further improve the data analysis, it would be valuable to 
map the recorded region of the sensorimotor cortex prior to induction of the ischem-
ic stroke by, for example, recording the evoked responses to tactile stimulation ap-
plied via a piezoelectric device, as described by Sigler et al. (Sigler, Mohajerani, & 
Murphy, 2009). This information may then be overlaid on the 2D map that describes 
the neural activity within the MEA recording area (see Sec. 4.6.1). In this way, it 
may be possible to investigate if the electrophysiological changes had an inclination 
towards occurring within another specific subregion of the sensorimotor cortex. 
6.2. MONITORING ISCHEMIC STROKE BY USE OF MICROE-
LECTRODE ARRAYS 
MEAs make it possible to simultaneously record or stimulate large populations of 
excitable cells over long periods of time (i.e., up to several months) (Flint, Wright, 
Scheid, & Slutzky, 2013; Hofmann & Bading, 2006; M. D. Murphy, Guggenmos, 
Bundy, & Nudo, 2015; Spira & Hai, 2013; Vetter et al., 2004). They have frequently 
been used to investigate the cell functionality and plasticity as well as to decode 
brain activity patterns (Laubach, Wessberg, & Nicolelis, 2000; Lebedev & Nicolelis, 
2006; M. A. Nicolelis et al., 1997; M. A. L. Nicolelis, 2009). MEAs have, however, 
not been extensively used to investigate the effect of ischemic stroke on the neural 
tissue (Jensen et al., 2006). 
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In the present work, the use of MEAs made it possible to investigate the electro-
physiological changes following ischemic stroke with high spatial and temporal 
resolution during the entire course of the ischemic stroke (acute to chronic phase). 
The obtained results are in line with what has previously been documented concern-
ing the progression of ischemic stroke. Study I showed that hyperexcitability oc-
curred within the neural networks following ischemic stroke and that the spread of 
hyperexcitability could be closely monitored. Previously, hyperexcitability in the 
acute phase of ischemic stroke has been documented by Sigler et al. (Sigler et al., 
2009) using VSDI and Fujioka et al. (Fujioka, Kaneko, Suzuki, & Mabuchi, 2004) 
using cortical surface electrodes. The results in the present work additionally re-
vealed that the neural networks changed their response patterns. As such, more tem-
porally diffuse neural responses were observed in some neural networks, whereas in 
others, the neural responses became more focused.  
Study IV showed that the neural response patterns changed and functional reorgani-
zation occurred as recovery took place during the subacute and chronic phases. Sim-
ilar reorganization has been documented by Nudo et al. (Randolph J Nudo et al., 
1996) in adult squirrel monkeys that were subjected to rehabilitative training.  
6.3. LOW-FREQUENCY ELECTRICAL STIMULATION AS A NEU-
ROPROTECTION INTERVENTION 
Lf-ES applied to the ischemia-affected brain has recently been suggested as a novel 
approach for inducing neuroprotection in the acute phase of ischemic stroke (Plow & 
Machado, 2013). Baba et al. (Baba et al., 2009) exposed rats to epidural electrical 
stimulation (frequency = 2 Hz, amplitude = 100 μA, pulse width = 1 ms square-wave 
pulses) directly following a transient ischemic stroke. The stimulation was main-
tained for up to one week and showed that lf-ES may trigger a myriad of neuropro-
tective mechanisms, thereby improving behavioral function, reducing cell death 
(both necrotic and apoptotic), and facilitating angiogenesis. 
Studies II-III showed that the hyperexcitability that spread throughout the sen-
sorimotor cortex could be minimized by lf-ES. As such, it is suggested that the ap-
plication of lf-ES may have caused the neurons to become less sensitive to the large 
amount of neurotransmitters within the extracellular space which, in turn, could 
result in the minimization of excitotoxicity and PIDs (Collingridge, Peineau, 
Howland, & Wang, 2010; Harvey & Nudo, 2007; Luscher & Malenka, 2012). This 
suggestion is based on previous research, where similar stimulation paradigms have 
been used to induce LTD in healthy tissue (Bliss & Cooke, 2011; Hess & Donoghue, 
1996; Luscher & Malenka, 2012). Recalling that the IC recordings are most likely 
obtained from neural networks situated within the lesser-affected regions of the 
penumbra or in healthier tissue (see Sec. 6.1.2 and Sec. 6.1.3), it may also be the 
case that the decreased hyperexcitability instead reflects a reversal of diaschisis. 
Consequently, further investigation of the effect of lf-ES is needed to establish the 
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specific cause of the reduction in hyperexcitability. Finally, lf-ES should be tested 
after delaying the intervention (e.g., 2 – 3 hours) to investigate the robustness of the 
intervention in relation to the treatment time (see Sec. 2.3.1). 
6.4. THE EXISTENCE OF A CRITICAL PERIOD OF INCREASED 
REHABILITATION EFFICIENCY 
The existence of a critical period where rehabilitation may be particularly efficient 
in promoting recovery has been postulated to exist in both rats and humans (see Sec. 
2.3.3). In rats, this period has been proposed to span from day 5 to day 14 after the 
ischemic insult, and initiating rehabilitation or forcing the subject to use the im-
paired limb earlier than day 5 has been shown to result in less recovery and an en-
largement of the ischemic territory (Bland et al., 2000; Humm et al., 1998; 
Kozlowski et al., 1996). 
Study IV showed that the initiation of rehabilitation prior to or within the critical 
period resulted in a similar degree of recovery of skilled movement at the termina-
tion of the experiment. As such, both groups of animals recovered to the degree at 
which the beam traversal performance was similar to that of healthy state. On the 
contrary, the hindlimb movement pattern during treadmill walking was significantly 
different from that of the healthy state for both groups. Initiating rehabilitation with-
in the critical period, though, resulted in hindlimb movement patterns that were 
more similar to those of the healthy state at the termination of the experiment.  
The assessment of the electrophysiological characteristics showed that the hindlimb 
area expanded and that the neural activity patterns were significantly altered when 
initiating rehabilitation prior to the critical period. An expansion of the hindlimb 
area was not observed when initiating rehabilitation within the critical period, and 
the neural activity patterns were more similar to those healthy state. Previously, 
Kozlowski et al. (Kozlowski et al., 1996) found that the very early use of the im-
paired limb resulted in increased tissue loss. It is believed that this may also have 
occurred in the present study and that the larger degree of cortical reorganization and 
electrophysiological changes reflected an increased demand of the brain to compen-
sate for the exacerbated injury. This may also be reflected in the large alteration in 
the movement pattern of the hindlimb. 
6.5. LIMITATIONS AND PERSPECTIVES OF THE ISCHEMIC 
STROKE MODEL 
As described in Section 6.1.3, the ischemic core and penumbra could not be verified 
by the electrophysiological recordings in the present work. Therefore, the MEA 
should be redesigned and at the same time used in connection with histological 
techniques to provide a second estimate of the infarct size. Utilizing histological 
techniques, though, raises an issue in reproducing Studies I-III, as it is difficult to 
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calculate the infarction volume very soon after the ischemic insult. This is due to the 
ischemic changes taking up to 24 hours to mature into a well-demarcated infarct that 
may be observed on the histological exhibits (Liu et al., 2009). Thus, the experiment 
should be prolonged to enable the ischemic changes to mature and could with bene-
fit be extended into the chronic phase to accommodate the guidelines of STAIR 
(Fisher et al., 2009; STAIR, 1999), which suggest that monitoring of ischemic stroke 
and recovery should be performed from the acute to the chronic phase to properly 
assess the effects of interventions. 
In the present work, the electrophysiological characteristics of the ischemic brain 
were investigated by analyzing the sensorimotor cortex responses to hindlimb-
related sensory inputs (Studies I-III) and the sensorimotor cortex activity during 
walking on a motorized treadmill (Study IV). In future work, the spontaneous activ-
ity of the ischemia-affected neural networks may be recorded, as it would be of high 
value to verify the occurrence of PIDs and investigate whether lf-ES reduces these. 
PIDs have previously been recorded in mice by Risher et al. (Risher et al., 2010) 
with a glass microelectrode inserted within layer I of the sensorimotor cortex. Fur-
ther, it would be of relevance to record from the rostral motor area (which has a 
resemblance to the supplementary motor area and premotor area of primates) or the 
contralateral homotopic regions because the electrophysiological properties of these 
areas change as a consequence of the ischemic stroke and subsequent recovery 
(Dancause & Nudo, 2011; Dancause et al., 2006; Eisner-Janowicz et al., 2008; Kopp 
et al., 1999; Mohajerani et al., 2011). 
Finally, to improve the clinical relevance of future research, it may be beneficial to 
translate the model onto an animal with a higher degree of physiological similarity 
to humans, such as pigs (Fisher et al., 2009; STAIR, 1999). The pig has an gyrence-
phalic brain and has previously been used in acute ischemic stroke experiments by 
Sakoh et al. (Sakoh, Rohl, et al., 2000) and Røhl et al. (Røhl et al., 2001) to investi-
gate cerebral blood flow and the penumbra by use of MRI. 
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CHAPTER 7. CONCLUSIONS 
The present thesis hypothesized that utilizing microelectrode arrays to monitor intra-
cortical electrophysiological signals would provide novel insight into ischemic 
stroke and can be a useful tool for testing novel approaches for neuroprotection and 
rehabilitation interventions. The hypothesis was tested in a rat model of ischemic 
stroke. 
Study I sought to establish novel methods and techniques for the use of MEAs. 
Studies II-III utilized these novelties to investigate the neuroprotective effect of lf-
ES, and Study IV investigated the existence of a critical period in which the initia-
tion of rehabilitation is especially efficient in promoting recovery, whereas initiating 
rehabilitation prior to this period may exacerbate injury.  
The thesis showed that the use of MEAs allowed for monitoring the electrophysio-
logical properties of the ischemia-affected brain in high spatial and temporal resolu-
tion (Study I). This property is believed to be of high importance because it renders 
it possible to closely monitor the evolving ischemic stroke and can provide detailed 
information on the effects of neuroprotection and rehabilitation interventions. Lf-ES 
was found to be a promising neuroprotection intervention because it reduced the 
hyperexcitability within the penumbra and/or lesser-affected neural networks fol-
lowing ischemic stroke (Studies II-III). Finally, the existence of a critical period 
where rehabilitation may be especially efficient in promoting recovery was support-
ed, and it was observed that initiating rehabilitation prior to this period may exacer-
bate injury (Study IV). 
Thus, the thesis has demonstrated the novel and innovative use of MEAs in ischemic 
stroke research and has shown beneficial effects of novel approaches for neuropro-
tection and rehabilitation interventions. The work is believed to have a high poten-
tial as a basis for further studies on the underlying mechanisms of ischemic stroke 
and may assist in the design of more effective neuroprotection and rehabilitation 
interventions in the future. 
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